Janet Englund, MD, Professor of Pediatrics at University of Washington/Seattle Children’s Hospital, studies the diagnosis, prevention, and treatment of respiratory viruses.

She has studied new vaccines and prevention measures against respiratory diseases in children, pregnant persons, and immunocompromised patients, as well as antivirals for influenza and respiratory syncytial virus (RSV).

She has worked collaboratively on large single center and multicenter surveillance studies assessing community spread of respiratory viruses and vaccine effectiveness. Her research group has studied prevention of RSV disease in infants using passive monoclonal antibody and maternal immunization.

She works with the US CDC to assess the effectiveness of currently available vaccines and monoclonal antibodies in children and households.